Clinical Trials on End-Stage Renal Disease in United Kingdom

Total 138410 results

Fresenius Medical Care North America

Completed

Acid-Base Composition With Use of hemoDialysates (ABChD)

End Stage Renal Disease

United States
Vanderbilt University

Completed

Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence

End Stage Renal Disease

United States
University of Wisconsin, Madison
Genentech, Inc.

Withdrawn

Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant

End Stage Renal Disease

United States
Renal Research Institute

Completed

A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients (IAM)

End Stage Renal Disease

United States
Vanderbilt University

Completed

The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients

End Stage Renal Disease

United States
Vanderbilt University

Completed

The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis

End Stage Renal Disease

United States
Alkahest, Inc.

Completed

Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis

End-Stage Renal Disease

United States
University of Vermont
Icahn School of Medicine at Mount Sinai

Completed

Tele-palliative Care in Rural Dialysis Patients

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.

End Stage Renal Disease

United States
NYU Langone Health

Completed

The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients

End Stage Renal Disease

United States
Vanderbilt University Medical Center
Baxter Healthcare Corporation

Completed

Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers (RMFPC-12)

End Stage Renal Disease

United States
The Rogosin Institute
Weill Medical College of Cornell University

Completed

Treatment Modification to Reduce Symptom Burden in Hemodialysis

End Stage Renal Disease

United States
Youngstown State University

Terminated

Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population

End Stage Renal Disease

United States
Tampa General Hospital
CSL Behring

Completed

Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation

End Stage Renal Disease

United States
Vanderbilt University

Terminated

Protein Supplementation in Dialysis Patients

End Stage Renal Disease

United States
Vanderbilt University

Completed

The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients

End Stage Renal Disease

United States
Vanderbilt University
Ross Laboratories

Terminated

Complementary Intradialytic Nutritional Supplementation in Dialysis Patients

End Stage Renal Disease

United States
Barts & The London NHS Trust
Royal Marsden NHS Foundation Trust; Guy's and St Thomas' NHS Foundation Trust; Case Western Reserve University and other collaborators

Completed

Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma (MAPPING)

Endometrial Cancer | Surgically Staged Endometrial and Cervical Carcinoma | Cervical Cancer: Invasive Disease, FIGO Stage 1B1 or Higher | Stage 1A With Myometrial Invasion or Any Higher Stage and Grade 3 | Stage 1A With Myometrial Invasion or Any Other Higher Stage and Serous Papillary or... and other conditions

United Kingdom
Vanderbilt University

Completed

Omega-3 Fatty Acid Administration in Dialysis Patients

End Stage Renal Disease

United States
University of Kansas Medical Center
Novartis Pharmaceuticals

Recruiting

Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Calcineurin Inhibitors (CNIs) to Everolimus

End Stage Renal Disease

United States
Cedars-Sinai Medical Center
Astellas Pharma Inc

Completed

Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

End Stage Renal Disease

United States
Medical University of South Carolina
Genzyme, a Sanofi Company

Completed

Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists

End Stage Renal Disease

United States
University of Michigan
Hoffmann-La Roche

Completed

CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft Recipients

End Stage Renal Disease

United States
Lorenzo Gallon

Completed

Extended Release Tacrolimus vs. Twice-Daily Tacrolimus

End Stage Renal Disease | Rejection of Renal Transplant

United States
University of Southern California
National Cancer Institute (NCI)

Active, not recruiting

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Healthy Subject | Stage I Renal Cell Cancer | Stage II Renal Cell Cancer

United States
Montefiore Medical Center

Terminated

Anesthetic Technique for AV Fistulae Creation

End Stage Renal Failure on Dialysis

United States
Acacia Pharma Ltd

Completed

PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment

Renal Disease, End Stage

United States
Arkansas Children's Hospital Research Institute

Terminated

Single Dose Pravastatin Pharmacokinetics in Pediatric Peritoneal Dialysis Patients

End Stage Renal Disease

United States
Penn State University
University of Pennsylvania; University of Alabama at Birmingham

Recruiting

Network Interventions to Reduce Disparities in Living Kidney Donation

End-stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

Triferic AVNU Infusion Via Freedom Pump During Hemodialysis

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients

End Stage Renal Disease

United States
Northwestern University

Completed

Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients (TRACT)

End Stage Renal Disease

United States
Rockwell Medical Technologies, Inc.

Completed

Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients

End Stage Renal Disease

United States
William Beaumont Hospitals
Wayne State University

Completed

Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients

End Stage Renal Disease

United States
Prolong Pharmaceuticals

Completed

Study to Assess the Safety and Impact on Humoral Sensitization of SANGUINATE in Patients With End Stage Renal Disease

Renal Insufficiency, Chronic

United States
Blood Purification Technologies, Inc.
University of Washington; Wearable Artificial Kidney Foundation

Completed

24 Hour Use of the Wearable Artificial Kidney (WAK US 1)

End Stage Renal Disease

United States
Bristol-Myers Squibb

Completed

Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis

End Stage Renal Disease

United States
Drexel University College of Medicine
Novartis

Terminated

Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant (Simulect)

End Stage Renal Disease

United States
Case Western Reserve University

Completed

Transplant Navigator Intervention to Overcome Barriers to Kidney Transplantation

End Stage Renal Disease

United States
National Institute of Diabetes and Digestive and...
Washington University School of Medicine; University of Alabama at Birmingham; Icahn School of Medicine at Mount Sinai and other collaborators

Completed

Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis (HEMO)

End Stage Renal Disease

United States
University of Michigan
Renal Research Institute

Terminated

Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients (ESRD)

End Stage Renal Disease | Acute Kidney Injury | Chronic Kidney Disease Stage 5

United States
LeMaitre Vascular

Terminated

Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts

End Stage Renal Disease

United States
Pursuit Vascular, Inc.
Fresenius Medical Care North America

Completed

Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap

End Stage Renal Disease (ESRD)

United States
Diaxamed LLC

Terminated

A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement

End Stage Renal Disease

United States
Angiotech Pharmaceuticals

Terminated

Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access

Hyperplasia | End Stage Renal Failure on Dialysis

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Clear Cell Sarcoma of the Kidney | Papillary Renal Cell Carcinoma | Rhabdoid Tumor of the Kidney | Stage I Renal Cell Cancer | Childhood Renal Cell Carcinoma | Stage II Renal Cell Cancer | Stage I Renal Wilms Tumor and other conditions

United States, Canada, Australia, New Zealand, Puerto Rico
University of Wisconsin, Madison
Millennium Pharmaceuticals, Inc.

Completed

Ixazomib for Desensitization (IXADES)

Kidney Diseases | End Stage Renal Disease

United States
Biomedical Enterprises Inc
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Unknown

New Needle for Two-Needle Hemodialysis (BME-1)

End Stage Renal Disease

United States

Clinical Trials on End-Stage Renal Disease in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations